Neopenda

Life-saving technology for the world's most vulnerable newborns

https://wefunder.com/neopenda

Total raised on Wefunder: 272235

Total investors: 224

Quick facts

  • 150,000+ monitoring hours across 50+ hospitals, 5,000+ newborns no longer left unseen
  • 53% YoY sales growth in Kenya
  • $6M+ from Fortune 500s, global health foundations, and top accelerators including Techstars
  • Patented, CE-marked, ISO 13485 certified, a validated commercial product
  • Built by Columbia-trained biomedical engineers with Medtronic, GSK, and Eli Lilly team experience
  • Qualified by WHO andUNITAID as a breakthrough technology for low-resource settings

Team profiles

Featured investor profiles

Neopenda

Life-saving technology for the world's most vulnerable newborns

Funded badge
Last Funded May 2026

$1,192,235

raised from 224 investors

What Investors Say

Director
LEAD INVESTOR
Invested $15,000 this round
Prior to founding My village health, We have dedicated our careers to advancing medical solutions that serve patients where they are — not where we think they should be. As healthcare professionals of African origin who have global work experience and deep roots in Africa, we understand that scalable, sustainable healthcare solutions in Africa must be designed, scaled and delivered for the local context, with the local market uniqueness in mind. This is the ethos that drives our work at my village health, and is the very foundation upon which Neopenda is built. We have been closely following Neopenda’s journey over the past year and have been deeply impressed with their clarity of purpose, their relentless focus on impact, and most importantly, their traction on the ground. Their flagship product, neoGuard, is not just a wearable vital signs monitor — it’s a lifeline for patients and a critical decision-making tool for overburdened health workers in underserved areas. In an environment where too many lives are lost due to preventable causes, the impact of a solution like this is monumental. But what makes us even more excited is Neopenda’s vision beyond a single product. They are not just building devices — they are building an ecosystem of locally relevant, data-driven health technologies that have the potential to transform primary care delivery across Africa. This is exactly the kind of thinking and innovation that My Village Health is designed to support. We invested because we believe Neopenda is one of the rare startups that is both mission-aligned and market-savvy. They understand how to build in partnership with health systems, how to scale responsibly, and how to meet the unique challenges of operating in African markets. And their team? They are exceptional. Smart, driven, humble, and deeply committed to patients — the kind of team you want to bet on. Whether you're passionate about social impact, eager to diversify your investment portfolio with a high-growth company, or simply want to support an African-led innovation with global relevance — Neopenda is a compelling opportunity. This is not just a cause. It’s a smart investment in a team and a technology that are both making a difference and positioned for real value and commercial success in regions with high population growth. You don’t have to be a global health expert to see the value here — you just have to recognize a company that’s solving big problems in smart, scalable ways for large populations. We are proud to back Neopenda, and we invite you to join us in supporting a company that is not only transforming healthcare but also redefining what’s possible in emerging markets
What People Say